Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
Study NCT ID:
NCT04231292
Status:
UNKNOWN
Last Update Posted:
2020-01-18
First Post:
2020-01-14
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
Sponsor:
Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-14
First Submit QC Date:
None
Study First Post Date:
2020-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-15
Last Update Post Date:
2020-01-18
Last Update Post Date Type:
ACTUAL